Thalidomide is a medication with several different effects, one of which is promoting sleep in the context of insomnia. In a new study, researchers from the University of Tsukuba have discovered that ...
A decade after receiving funding from the federal government, thalidomide survivors say it has helped make difficult days ...
In the midst of the coronavirus pandemic, researchers have turned to existing medicines to see whether they can be repurposed to treat COVID-19. And surprisingly, the drug thalidomide is also being ...
Neil Vargesson receives or has received funding for thalidomide research from the Wellcome Trust, the Royal Society, University of Aberdeen, Imperial College London and the National Institutes of ...
The claim: Thalidomide, a rapidly approved drug, was banned in the early 1960s after it was discovered to cause birth defects in newborns. Thalidomide and its side effects continue to be cited by ...
Thalidomide, a sedative that caused severe birth defects 50 years ago when it was prescribed to pregnant women, has enjoyed revived interest owing to its potency as an antiangiogenic and ...
Scientists have found a new piece of the puzzle about how the drug thalidomide caused devastating birth defects in thousands of children whose mothers took the drug while pregnant more than 60 years ...
Thalidomide was developed as a non-barbiturate sedative (non-addictive sleep aid) in Germany during the 1950s. It was removed from the market in 1961 after it was linked to major birth defects in ...
Neil Vargesson receives or has received funding for thalidomide research from the Wellcome Trust, the Royal Society, University of Aberdeen, Imperial College London. I have previously been consulted ...
The ongoing repurposing of the infamous drug thalidomide may include treatment of Crohn’s disease, an incurable bowel condition. Thalidomide was banned or never approved in many countries because it ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Treatment with ...
Relevance of Bone Marrow Cell Dose on Allogeneic Transplantation Outcomes for Patients With Acute Myeloid Leukemia in First Complete Remission: Results of a European Survey PURPOSE: Multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback